Systane
Systane is a pharmaceutical drug with 14 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.7%
11 of 12 finished
8.3%
1 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
Artificial Tears Study in Mild to Moderate Dry Eye Patients
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
Clinical Trials (14)
Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
Artificial Tears Study in Mild to Moderate Dry Eye Patients
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
Tears Substitutions and Their Effects on Higher Order Aberrometery
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
Systane Clinical Experience Study
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14